Author

Rob L. M. van Montfort

Institute of Cancer ResearchORCID 0000-0002-5688-3450Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Assay:protein structure· 1

Frequent Co-Authors

John CaldwelliD· 2 shared Yann‐Vaï Le BihaniD· 2 shared Agnieszka KonopackaiD· 1 shared Andrea ScarpinoiD· 1 shared Bachuki ShashikadzeiD· 1 shared Bjoern Schwalb· 1 shared Denise Winkler· 1 shared Ellie Stammers· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

John CaldwellORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 2, 2026

Developing Potent and Selective TBK1 Molecular Glue Degraders for Cancer Immunotherapy

John Caldwell, Patrick R. A. Zanon, Iona Ferguson…·Zoran Ranković

This paper develops a first-in-class TBK1 molecular glue degrader, CCT412020, which enhances anti-tumour immunity and overcomes immune checkpoint blockade resistance.

2 citations

humanexperimental assay

BiochemistryScientific ReportsPeer-reviewedNov 20, 2025

Discovery of first-in-class inhibitors of the TRF1-TIN2 protein-protein interaction by fragment screening

Giacomo Casale, Manjuan Liu, Yann‐Vaï Le Bihan…·Sebastian Guettler

The paper identifies a first-in-class inhibitor of the TRF1-TIN2 protein-protein interaction using fragment screening and structural methods.

DOI 10.1038/s41598-025-23858-3

protein structureexperimental assay